Literature DB >> 7499254

Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.

R M Richardson1, H Ali, E D Tomhave, B Haribabu, R Snyderman.   

Abstract

To define the molecular mechanisms of cross-regulation among chemoattractant receptors, we stably coexpressed, in a rat basophilic leukemia (RBL-2H3) cell line, epitope-tagged receptors for the chemoattractants formylmethionylleucylphenylalanine (fMLP), a peptide of the fifth component of the complement system (C5a), and interleukin-8 (IL-8). All the expressed receptors underwent homologous phosphorylation and desensitization upon agonist stimulation. When co-expressed, epitope-tagged C5a receptor (ET-C5aR) and epitope-tagged IL-8 receptor (ET-IL-8RA) were cross-phosphorylated by activation of the other. Activation of epitope-tagged fMLP receptor (ET-FR) also cross-phosphorylated ET-C5aR and ET-IL-8RA, but ET-FR was totally resistant to cross-phosphorylation. Similarly, C5a and IL-8 stimulation of [35S]guanosine 5'-3-O-(thio) triphosphate (GTP gamma S) binding and Ca2+ mobilization were cross-desensitized by each other and by fMLP. Stimulation of [35S]GTP gamma S binding by fMLP was also not cross-desensitized by C5a or IL-8, however, Ca2+ mobilization was, suggesting a site of inhibition distal to G protein activation. Consistent with this desensitization of Ca2+ mobilization, inositol 1,4,5-trisphosphate release in RBL-2H3 cells expressing both ET-C5aR and ET-FR revealed that fMLP and C5a cross-desensitized each other's ability to stimulate phosphoinositide hydrolysis. Taken together, these results indicate that receptor cross-phosphorylation correlates directly with desensitization at the level of G protein activation. The ET-FR was resistant to this process. Of note, cross-desensitization of ET-FR at the level of phosphoinositide hydrolysis and Ca2+ mobilization was demonstrated in the absence of receptor phosphorylation. This suggests a new form of chemoattractant cross-regulation at a site distal to receptor/G protein coupling, involving the activity of phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499254     DOI: 10.1074/jbc.270.46.27829

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Roles of phospholipase C beta2 in chemoattractant-elicited responses.

Authors:  H Jiang; Y Kuang; Y Wu; W Xie; M I Simon; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

3.  Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.

Authors:  Yoshitaka Sogawa; Takao Ohyama; Hiroaki Maeda; Kazuki Hirahara
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

4.  HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

Authors:  H Ueda; O M Howard; M C Grimm; S B Su; W Gong; G Evans; F W Ruscetti; J J Oppenheim; J M Wang
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

5.  Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation.

Authors:  E F Foxman; E J Kunkel; E C Butcher
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

6.  Modulation of Human Neutrophil Responses by the Essential Oils from Ferula akitschkensis and Their Constituents.

Authors:  Igor A Schepetkin; Svetlana V Kushnarenko; Gulmira Özek; Liliya N Kirpotina; Pritam Sinharoy; Gulzhakhan A Utegenova; Karime T Abidkulova; Temel Özek; Kemal Hüsnü Can Başer; Anastasia R Kovrizhina; Andrei I Khlebnikov; Derek S Damron; Mark T Quinn
Journal:  J Agric Food Chem       Date:  2016-09-13       Impact factor: 5.279

Review 7.  How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Authors:  Krishna Rajarathnam; Michael Schnoor; Ricardo M Richardson; Sudarshan Rajagopal
Journal:  Cell Signal       Date:  2018-11-19       Impact factor: 4.315

Review 8.  Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.

Authors:  Bhawna Sharma; Seema Singh; Michelle L Varney; Rakesh K Singh
Journal:  Expert Opin Ther Targets       Date:  2010-04       Impact factor: 6.902

9.  A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.

Authors:  Valérie Capra; Maria Rosa Accomazzo; Fabrizio Gardoni; Silvia Barbieri; G Enrico Rovati
Journal:  J Lipid Res       Date:  2009-11-15       Impact factor: 5.922

Review 10.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.